Batm Advanced Communicat... Share Discussion Threads

[landskermichael] 08/12/2022 08:24

Well at least they have done something even if its nothing that was not known already , Armageddon is written into the price , its a day traders stock now , looking around other forums , the general consensus is its being manipulated by the market makers for their own benefit , they would counter by saying buyers are welcome to force us put it upwards but that's the problem , buyers are frozen with fear , suckers are selling , the wise are buying , time will prove that, anybody buying this stock for he first time right now , the downside is 16 p the upside is 50 p for the next 2 years barring something we don't know about , a far safer bet that most stocks , just my opinion though

[rawdeal1] 08/12/2022 08:17

This is the sticking point ...
"Whilst the Group has had good visibility on this project, given that it is now December, should the contract be received and signed, the revenue would be recognised in 2023 thereby impacting current year expectations for revenue by the corresponding amount and, accordingly, reducing FY 2022 EBITDA."

[resistance1] 08/12/2022 08:11

Makes the prospects for next year look good if they kick off with this chunky order. Looks like the market had already written off this year.

[zipstuck] 08/12/2022 08:07

I had always worked on the assumption that Covid revenues would wind down and that the company should be valued with out them

I am more focused on what else is going on with the company. Very happy with that.

Kooba if the contract is awarded the cash position will dramatically improve.

[reeltime] 08/12/2022 08:06

The update is most welcome but the lack of numbers is concerning!

[echoridge] 08/12/2022 08:06

Perhaps this is the final release that was blocking the buyback.

[74tom] 08/12/2022 07:48

A 20% fall over the last 5 days and then release a profit warning, this should be suspended pending an explanation for the downward price movement by the company. Avoid like the plague.

[scepticalinvestor] 08/12/2022 07:44

Profit warning...

[doccash] 08/12/2022 07:44

Can we have a comment from the clowns today. Always good for a laugh.

[kooba] 08/12/2022 07:32

The company started the year with $67m and now has $40m..this is some cash burn ! Not all explained but the company is certainly not cash flow positive !

[wizzkid211] 08/12/2022 07:31

the Group entered the second half with sustained momentum and a significant backlog to be delivered against.
NO NUMBES BUT LOOKING VERY GOOD!

[wizzkid211] 08/12/2022 07:29

BATM is profitable with a very strong balance sheet comprising both cash and investments in financial assets of approximately $40m as well as property and valuable IP. Accordingly, the Board of BATM remains confident in the prospects for the business and continues to explore all options to deliver shareholder value

[wizzkid211] 08/12/2022 07:28

BATM Advanced Communications Ld

08 December 2022

LEI: 213800FLQUB9J289RU66

8 December 2022

BATM Advanced Communications Limited

("BATM" or "the Group")

Trading Update

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, provides the following update on its trading for FY 2022.

As stated in its interim results announcement of 24 August 2022, the Group entered the second half with sustained momentum and a significant backlog to be delivered against. BATM made solid progress in both of its divisions as business returns to normality post-pandemic, notwithstanding supply chain issues.

Networking and Cyber Division

In the second half of the year, BATM was delighted to announce a multi-year contract for its Edgility solution with UK-based CityFibre in the Networking unit. Work to date reinforces the Group's expectation that deployment and recurring revenues will scale meaningfully in the short term. The Group is also pleased that Edgility is fast being recognised internationally as a breakthrough solution and is winning several awards. Consequently, the interest in Edgility has seen a significant increase and the Group is in advanced discussions with several customers.

BATM's Cyber business also made good progress in the second half of the year as the need for cyber security increases daily due to the geo-political situation as well as increased organised criminal activity. As such, the Group's confidence in this unit remains high and it is optimistic of winning a substantial multi-year, multi-million dollar government contract, which would increase the revenues of this division in 2023 and beyond.

Bio-Medical Division

In the Diagnostics unit of the Bio-Medical division, the COVID-19 pandemic has demonstrated the capability and value of BATM's diagnostic IP and products. Whilst the transition from the peak pandemic revenues of 2021 introduced an element of volatility to the unit's trading, its performance in 2022 nonetheless indicates its brighter prospects for 2023. In particular, in 2022, the unit's sale of non-COVID diagnostics product saw a dramatic volume increase. From being practically non-existent in 2021, the Group expects to report low double-digit million dollar revenues for sales of its non-COVID diagnostic products this year.

Pandemics remain a genuine global concern and COVID remains a very live issue in Asia. The Diagnostic unit was informed that it is due to be awarded a major tender, with a value of $25m, from a customer in Southeast Asia primarily for the delivery of COVID-19 testing kits, and the Group has been awaiting a signed contract. Whilst the Group has had good visibility on this project, given that it is now December, should the contract be received and signed, the revenue would be recognised in 2023 thereby impacting current year expectations for revenue by the corresponding amount and, accordingly, reducing FY 2022 EBITDA.

The Eco-Med and Distribution units of the Bio-Medical division have continued to perform in line with management's expectations.

BATM is profitable with a very strong balance sheet comprising both cash and investments in financial assets of approximately $40m as well as property and valuable IP. Accordingly, the Board of BATM remains confident in the prospects for the business and continues to explore all options to deliver shareholder value.

Enquiries:

[kooba] 08/12/2022 07:28

Um ..this is a profits warning!...."2023 thereby impacting current year expectations for revenue by the corresponding amount and, accordingly, reducing FY 2022 EBITDA."Ie the revenues for current year are going to be $25m light of market forecast of $147m. What this translates to in EBITDA who knows but im sure SHORE CAP will let us know later!It might be dressed up as positive but this year was going to be the inflection year instead it is turning bad...as with all things BATM next year will be the big one..jam tomorrow as always.The cash position has fallen again from the half year from $47m to $40m from the looks of it..no div no share buyback no noticeable subsid investment.Het least they managed to keep it under wraps and the price didnt crater before the update !!!

[oakville] 08/12/2022 07:19

PE under 8. !!!

[oakville] 08/12/2022 07:18

Well something doesn't add up?
Very good update profitable going forward. So why are these shares so dam cheap?

[oakville] 08/12/2022 07:17

Pandemics remain a genuine global concern and COVID remains a very live issue in Asia. The Diagnostic unit was informed that it is due to be awarded a major tender, with a value of $25m, from a customer in Southeast Asia primarily for the delivery of COVID-19 testing kits, and the Group has been awaiting a signed contract. Whilst the Group has had good visibility on this project, given that it is now December, should the contract be received and signed, the revenue would be recognised in 2023 thereby impacting current year expectations for revenue by the corresponding amount and, accordingly, reducing FY 2022 EBITDA.

The Eco-Med and Distribution units of the Bio-Medical division have continued to perform in line with management's expectations.

BATM is profitable with a very strong balance sheet comprising both cash and investments in financial assets of approximately $40m as well as property and valuable IP. Accordingly, the Board of BATM remains confident in the prospects for the business and continues to explore all options to deliver shareholder value.

[gbenson1] 08/12/2022 07:10

At long last a trading update, aimed at assuring the markets, nice $25m tender almost in the bag, how will the markets react? Time will tell..

[kooba] 08/12/2022 06:54

Of course a way of privatising is to simply delist...say the company is well funded (something Shore used) , say they can better focus on growing the business away from the bother of listing. Develop the businesses to achieve the best value to monetisation possibly IPO or trade sale divisions once market is more amenable . Institutions such as LO can retain their interest and likely justify an independent valuation as a private business somewhat higher than current share price.Company can argue the market does not recognise the value in the business and that it is self financing and does need recourse to the stock market to raise additional funds ( explains the lack of buy back) It may well be a sensible option long term..however some will not be able to hold unlisted investments..often smaller shareholders in isa's but also some institutions will not have the remit.Modus operandiCome out with poor trading citing delays.Say you are considering delisting.Price shock.Call a GM to approve delisting ..ZVI and LO already on board?Get approval ?Make a small buyback at low level to mop up distressed sellers.Private company.Just a thought.

[shiftytherat] 07/12/2022 22:15

Maybe LO would be agreeable to a take private? Removes any obligation to sell it. But for them, I'd presume the position would need to be small for that to be acceptable. If a position is entirely illiquid, you want it as small as possible, so people ask fewer questions. In fact, maybe they are driving this. Make it small, take it private, stay quiet, it goes away...

[shiftytherat] 07/12/2022 22:07

Yeah, I'm honestly not trying to cause a stir here, but does anyone on here know what the rules would be? For instance, could they take it private with, say, 51% of the vote in favour? I presume it's higher than that, but does it depend on Israeli rules or those in London? I must admit, I have no idea.

[car1pet] 07/12/2022 17:53

When you say "take it private" that means Lombard Odier will take a large loss even if the buyer offers 30p. If I was offered 50p Id take it as would most shareholders so yes it could go private but not at 22p. IMO DYOR

[shiftytherat] 07/12/2022 17:28

"after following its days in the 90s"!

ha ha ha. 90s.... ha ha ha. Bravo, sir, bravo.

You know that this chat thread is called "New Beginning"? First post, 2006... Ha ha ha.

Let's agree to disagree. But let's agree that this is at best a trader's stock.

On the assumption that the net cash balance is indeed as sizable as they claim (which it probably is - although I was born a sceptic) it would be INSANE not to take this company private. I think that's the move.

(no position.)